Apella Capital’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Buy
3,943
+593
+18% +$180K 0.02% 331
2026
Q1
$896K Buy
3,350
+152
+5% +$34K 0.01% 380
2025
Q4
$547K Buy
3,198
+21
+0.7% +$3.27K 0.01% 342
2025
Q3
$452K Buy
3,177
+51
+2% +$5.4K 0.01% 339
2025
Q2
$307K Sell
3,126
-155
-5% -$12.3K 0.01% 349
2025
Q1
$233K Buy
3,281
+27
+0.8% +$2.13K 0.01% 352
2024
Q4
$235K Sell
3,254
-29,576
-90% -$2.24M 0.01% 314
2024
Q3
$262K Buy
32,830
+29,670
+939% +$2.58M 0.01% 283
2024
Q2
$352K Buy
3,160
+10
+0.3% +$959 0.02% 235
2024
Q1
$307K Hold
3,150
0.02% 243
2023
Q4
$230K Buy
+3,150
New +$215K 0.01% 265

Other funds holding LRCX

Apella Capital's LRCX Position: Q2 2026 in Review

Apella Capital increased its Lam Research (LRCX) stake by 18% in Q2 2026, buying an estimated $180K and bringing the position to 3,943 shares worth $1.29M. The position accounts for 0.02% of the portfolio, ranked #331.

Apella Capital first reported a position in LRCX in Q4 2023 and has held it in 11 quarters since. 988 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Apella Capital held 3,943 shares of Lam Research worth $1.29M as of Q2 2026.
  • Apella Capital bought 593 Lam Research shares in Q2 2026, an estimated $180K.
  • Lam Research made up 0.02% of Apella Capital's portfolio in Q2 2026, its #331 holding.
  • Apella Capital first reported a position in Lam Research in Q4 2023 and has held it in 11 quarters since.
  • 988 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Apella Capital's 13F filing for Q2 2026, filed 8 Jul 2026.